XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Research and development expenses $ 460 $ 309
Marketing expenses 23
General and administrative expenses 633 564
Total operating expenses 1,093 896
Operating loss 1,093 896
Financing expense, net 8
Loss for the period 1,093 904
Other comprehensive income:    
Foreign currency translation income (7) (22)
Comprehensive loss for the period $ 1,086 $ 882
Loss per share (Basic and Diluted) $ (0.07) $ (0.06)
Weighted average number of common stock outstanding used in computing basic and diluted net loss per share 15,461,757 15,444,697